NYXH
Nyxoah SA · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website nyxoah.com
- Employees(FY) 137
- ISIN BE0974358906
Performance
-24.24%
1W
-18.0%
1M
-47.44%
3M
+46.74%
6M
+50.22%
YTD
-12.38%
1Y
Profile
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Technical Analysis of NYXH 2024-05-31
Overview:
In analyzing the technical indicators for NYXH stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible future stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valu...
Recent News & Updates
- 2021-08-31 04:30
Nyxoah Issues First Half 2021 Financial Results(Yahoo Finance)
- 2021-08-29 20:36
Should You Buy Nyxoah (NYXH) Ahead of Earnings?(Yahoo Finance)
- 2021-08-11 04:30
- 2021-07-19 04:30
Publication relating to a transparency notification(Yahoo Finance)
- 2021-07-14 04:30
Publication relating to a transparency notification(Yahoo Finance)
- 2021-07-09 04:30
Information on the total number of voting rights and shares(Yahoo Finance)
- 2021-07-08 04:30
- 2021-07-01 20:40
Nyxoah Announces Pricing of Nasdaq Public Offering(Yahoo Finance)
Page 5 of 5
previousnext